Yongxiang Zhang
No.261, Taierzhuang South Road
Xianshuigu, 300222, China
Xianshuigu, 300222, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Two cases of pancytopenia characterized by severe neutropenia induced by anti-PD-1 tislelizumab combined with chemotherapy in non-small cell lung cancer patients and a literature review.
Journal: Frontiers in medicine
Published: March 01, 2026
MYO19 is associated with tumor progression, immune evasion, ferroptosis-related signatures in lung squamous cell carcinoma.
Journal: Frontiers in oncology
Published: October 17, 2025
Identifying diagnostic markers and establishing prognostic model for lung cancer based on lung cancer-derived exosomal genes.
Journal: Cancer biomarkers : section A of Disease markers
Published: April 03, 2025
Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial.
Journal: Cancer biology & medicine
Published: May 29, 2024
Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 18, 2020
Impact of chronic obstructive pulmonary disease on mortality in community acquired pneumonia: a meta-analysis.
Journal: Journal of comparative effectiveness research
Published: September 05, 2020
Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.
Journal: Experimental and therapeutic medicine
Published: February 14, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026